20107 results for «»

Filter By

20107 results

BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography

19 Sep 2022

Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.

It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Nicola Ryan

Author

Nicola Ryan
Trial Computed Tomography Cardiac Angiography Contrast Load Procedural Duration CABG Invasive Coronary Angiography

Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent

21 Jul 2022

Prevention of radial artery occlusion with rivaroxaban after transradial coronary procedures: The RIVARAD multicentric randomized trial

19 Sep 2022

Aaysha Cader interviews Rania Hammami, Principal Investigator of the RIVARAD trial. They discuss the design and results of the trial which was presented during #TCT2022.

RIVARAD is the first multicentric randomized trial with 30-day RAOs as the primary endpoint, which proved the efficacy of short-term use of...

Author

Aaysha Cader
Rania Hammami

Author

rania hammami
The RIVARAD Multicentric Randomized Trial: Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures

EXpansion of stents after Intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries: the EXIT-CALC – a prospective, randomized study

20 Sep 2022

Pierre Deharo and Michele Pighi share with us their views on the EXIT-CALC study presented by Thomas Oomens at TCT 2022.

Pierre Deharo

Author

Pierre Deharo
M. Pighi

Author

Michele Pighi
EXpansion of stents after Intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries: the EXIT-CALC – a prospective, randomized study

FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial

24 Aug 2022

The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).

Simone Fezzi

Reviewer

Simone Fezzi
M. Pighi

Reviewer

Michele Pighi
FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial

Expandable TAVR sheaths: which sheath fits which prosthesis?

01 Aug 2022

This toolbox provides interesting information on which expandable sheath fits which prosthesis.

Johannes Blumenstein

Author

Johannes Blumenstein
Expandable TAVR sheaths: which sheath fits which prosthesis?

REVIVED-BCIS2: no benefit of routine PCI in patients with reduced LVEF

13 Mar 2023

Dejan Milasinovic provides his take on the REVIVED trial - percutaneous revascularisation for ischaemic ventricular dysfunction, which was presented during ESC Congress 2022 in Barcelona.

Dejan Milasinovic

Author

Dejan Milasinovic
REVIVED - Percutaneous Revascularisation for Ischaemic Ventricular Dysfunction

ISCHEMIA-CKD EXTEND: revascularization does not improve outcomes at 5 years in patients with advanced chronic kidney disease

29 Aug 2022

Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up

PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

30 Aug 2022

Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Elad Asher

Author

Elad Asher
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

An interesting case of SCAD

17 May 2022 – From EuroPCR 2022

Discover the case of a 36 year-old woman presenting with squizzing central chest pain and referred for a primary PCI with impression of anterior STEMI. Angiography revealed a diffused significant lesion at mid-part of LAD. Watch the video to discover the treatment's option!

An interesting case of SCAD

RTC - Radial versus femoral access for coronary procedures

29 Aug 2022

Thirty years after the first radial access interventional coronary procedure the RTC trial provides evidence that radial access for coronary angiography or PCI is associated with lower risks of all-cause death and bleeding compared with femoral access. Mirvat Alasnag interviews Giuseppe Gargiulo regarding the methodology and...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Giuseppe Gargiulo

Author

Giuseppe Gargiulo
RTC - Radial versus femoral access for coronary procedures

Complex PCI after bypass grafts failure

17 May 2022 – From EuroPCR 2022

Discover the case of a 76 year-old female patient presenting with unstable angina, history of CABG and SVG and various risk factors (dyslipidemia, hypertension and type 2 diabetes). Angiography revealed a severe calcification of left main and left anterior descending artery with a tight stenosis, a...

Complex PCI after bypass grafts failure

COVID-PACT - Antithrombotic therapy in critically Ill COVID-19 patients

02 Sep 2022

Watch Luis Ortega Paz's interview with David Berg as part of the ESC 2022 Congress coverage, and find out more about the COVID-PACT trial, which aims to study antithrombotic strategies in critically ill COVID-19 patients. Learn more about the study design (population, primary endpoint, safety criteria...)...

David Berg

Author

David Berg
Luis Ortega-Paz

Author

Luis Ortega-Paz
COVID-PACT - Antithrombotic therapy in critically Ill COVID-19 patients

Fractured stent and aneurysmal expansion of the coronary artery

17 May 2022 – From EuroPCR 2022

Discover the case of a 51 year-old male presenting with stable angina, with an history of ischemic heart disease (stented several times), hypertension and benign lung tumor (active smoker). Angiogram revealed a mid LCx CTO, a mid LAD aneurysmal extended with distal part occluded and an...

Fractured stent and aneurysmal expansion of the coronary artery

Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

01 Sep 2022

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Daniele Giacoppo

Author

Daniele Giacoppo
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Repeat NSTEMI late after self-expanding TAVR

17 May 2022 – From EuroPCR 2022

Discover the case of a 79 year-old man presenting to the ER with NSTEMI and chest pain, with an history of NSTEMI with PCI and TAVR (CTO of the dominated RCA and intermediate stenosis of the proximal LAD). Angiography reveals a tight stenosis of proximal and...

Repeat NSTEMI late after self-expanding TAVR

PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction

28 Aug 2022

Ali Nazmi Calik asks trial investigator John Alexander about the design and results of the PACIFIC-AMI phase 2 trial, which revealed no increase in bleeding versus placebo.

Author

Ali Nazmi Calik

Author

John Alexander
PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction

INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation

28 Aug 2022

Aaysha Cader interviews Ganesan Karthikeyan who presented the results of INVICTUS during the ESC Congress 2022 in Barcelona: Among patients with rheumatic heart disease–associated atrial fibrillation, vitamin K antagonist therapy led to a lower rate of a composite of cardiovascular events or death than rivaroxaban therapy,...

Author

Aaysha Cader
Ganesan Karthikeyan

Author

Ganesan Karthikeyan
INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation

Severe coronary calcification: a setting for more than one lesion preparation method

17 May 2022 – From EuroPCR 2022

Discover the case of a 85 year-old male patient with an inferior NSTEMI, a severely reduced LVEF 20%, a symptomatic COVID-19 infection and various comorbidities. The RCA subocclusion was successfully stented, while the predilation of the proximal LAD calcification remained unsuccessful. How did the team treat...

Severe coronary calcification: a setting for more than one lesion preparation method

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
Didn’t find what you were looking for?